Full Text
Ranibizumab for the Treatment of Visual Impairment Due to Myopic Choroidal Neovascularization- Cost-Effectiveness Versus Aflibercept

Abstract

Authors

C. Leteneux J. Haig W. Xue S. Bhattacharyya

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×